Previous Article | Next Article 
Molecular and Cellular Biology, April 2006, p. 3266-3281, Vol. 26, No. 8
0270-7306/06/$08.00+0 doi:10.1128/MCB.26.8.3266-3281.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Differentiation of Trophoblast Giant Cells and Their Metabolic Functions Are Dependent on Peroxisome Proliferator-Activated Receptor ß/
Karim Nadra,1
Silvia I. Anghel,1,2
Elisabeth Joye,1
Nguan Soon Tan,1,
Sharmila Basu-Modak,1,
Didier Trono,2,3
Walter Wahli,1,2 and
Béatrice Desvergne1,2*
Center for Integrative Genomics, University of Lausanne, CH-1015 Lausanne, Switzerland,1
National Research Center "Frontiers in Genetics",
,
School of Life Sciences, Swiss Federal Institute of Technology, Lausanne, Switzerland3
Received 24 June 2005/
Returned for modification 21 July 2005/
Accepted 24 January 2006
Mutation of the nuclear receptor peroxisome proliferator-activated receptor ß/
(PPARß/
) severely affects placenta development, leading to embryonic death at embryonic day 9.5 (E9.5) to E10.5 of most, but not all, PPARß/
-null mutant embryos. While very little is known at present about the pathway governed by PPARß/
in the developing placenta, this paper demonstrates that the main alteration of the placenta of PPARß/
-null embryos is found in the giant cell layer. PPARß/
activity is in fact essential for the differentiation of the Rcho-1 cells in giant cells, as shown by the severe inhibition of differentiation once PPARß/
is silenced. Conversely, exposure of Rcho-1 cells to a PPARß/
agonist triggers a massive differentiation via increased expression of 3-phosphoinositide-dependent kinase 1 and integrin-linked kinase and subsequent phosphorylation of Akt. The links between PPARß/
activity in giant cells and its role on Akt activity are further strengthened by the remarkable pattern of phospho-Akt expression in vivo at E9.5, specifically in the nucleus of the giant cells. In addition to this phosphatidylinositol 3-kinase/Akt main pathway, PPARß/
also induced giant cell differentiation via increased expression of I-mfa, an inhibitor of Mash-2 activity. Finally, giant cell differentiation at E9.5 is accompanied by a PPARß/
-dependent accumulation of lipid droplets and an increased expression of the adipose differentiation-related protein (also called adipophilin), which may participate to lipid metabolism and/or steroidogenesis. Altogether, this important role of PPARß/
in placenta development and giant cell differentiation should be considered when contemplating the potency of PPARß/
agonist as therapeutic agents of broad application.
* Corresponding author. Mailing address: Center for Integrative Genomics, University of Lausanne, CH-1015 Lausanne, Switzerland. Phone: 41 21 6924140. Fax: 41 21 6924115. E-mail: beatrice.desvergne{at}unil.ch.
Present address: School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551, Singapore.
Present address: Department of Zoology, University of Dehli, Dehli 110007, India.
http://www.frontiers-in-genetics.org/en/index.php.
Molecular and Cellular Biology, April 2006, p. 3266-3281, Vol. 26, No. 8
0270-7306/06/$08.00+0 doi:10.1128/MCB.26.8.3266-3281.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Shan, W., Palkar, P. S., Murray, I. A., McDevitt, E. I., Kennett, M. J., Kang, B. H., Isom, H. C., Perdew, G. H., Gonzalez, F. J., Peters, J. M.
(2008). Ligand Activation of Peroxisome Proliferator-Activated Receptor {beta}/{delta} (PPAR{beta}/{delta}) Attenuates Carbon Tetrachloride Hepatotoxicity by Downregulating Proinflammatory Gene Expression. Toxicol Sci
105: 418-428
[Abstract]
[Full Text]
-
Rodriguez-Calvo, R., Serrano, L., Coll, T., Moullan, N., Sanchez, R. M., Merlos, M., Palomer, X., Laguna, J. C., Michalik, L., Wahli, W., Vazquez-Carrera, M.
(2008). Activation of Peroxisome Proliferator-Activated Receptor {beta}/{delta} Inhibits Lipopolysaccharide-Induced Cytokine Production in Adipocytes by Lowering Nuclear Factor-{kappa}B Activity via Extracellular Signal-Related Kinase 1/2. Diabetes
57: 2149-2157
[Abstract]
[Full Text]
-
Hollingshead, H. E., Borland, M. G., Billin, A. N., Willson, T. M., Gonzalez, F. J., Peters, J. M.
(2008). Ligand activation of peroxisome proliferator-activated receptor-{beta}/{delta} (PPAR{beta}/{delta}) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms. Carcinogenesis
29: 169-176
[Abstract]
[Full Text]
-
Wang, H., Xie, H., Sun, X., Tranguch, S., Zhang, H., Jia, X., Wang, D., Das, S. K., Desvergne, B., Wahli, W., DuBois, R. N., Dey, S. K.
(2007). Stage-specific Integration of Maternal and Embryonic Peroxisome Proliferator-activated Receptor {delta} Signaling Is Critical to Pregnancy Success. J. Biol. Chem.
282: 37770-37782
[Abstract]
[Full Text]
-
Hollingshead, H. E., Killins, R. L., Borland, M. G., Girroir, E. E., Billin, A. N., Willson, T. M., Sharma, A. K., Amin, S., Gonzalez, F. J., Peters, J. M.
(2007). Peroxisome proliferator-activated receptor- /{delta} (PPAR /{delta}) ligands do not potentiate growth of human cancer cell lines. Carcinogenesis
28: 2641-2649
[Abstract]
[Full Text]
-
Kennedy, T. G, Gillio-Meina, C., Phang, S. H.
(2007). Prostaglandins and the initiation of blastocyst implantation and decidualization. Reproduction
134: 635-643
[Abstract]
[Full Text]
-
Desmarais, J. A, Lopes, F. L, Zhang, H., Das, S. K, Murphy, B. D
(2007). The Peroxisome Proliferator-Activated Receptor Gamma Regulates Trophoblast Cell Differentiation in Mink (Mustela vison). Biol. Reprod.
77: 829-839
[Abstract]
[Full Text]
-
Feige, J. N., Gelman, L., Rossi, D., Zoete, V., Metivier, R., Tudor, C., Anghel, S. I., Grosdidier, A., Lathion, C., Engelborghs, Y., Michielin, O., Wahli, W., Desvergne, B.
(2007). The Endocrine Disruptor Monoethyl-hexyl-phthalate Is a Selective Peroxisome Proliferator-activated Receptor {gamma} Modulator That Promotes Adipogenesis. J. Biol. Chem.
282: 19152-19166
[Abstract]
[Full Text]
-
Wang, D., Wang, H., Guo, Y., Ning, W., Katkuri, S., Wahli, W., Desvergne, B., Dey, S. K., DuBois, R. N.
(2006). From the Cover: Crosstalk between peroxisome proliferator-activated receptor {delta} and VEGF stimulates cancer progression. Proc. Natl. Acad. Sci. USA
103: 19069-19074
[Abstract]
[Full Text]
-
Michalik, L., Auwerx, J., Berger, J. P., Chatterjee, V. K., Glass, C. K., Gonzalez, F. J., Grimaldi, P. A., Kadowaki, T., Lazar, M. A., O'Rahilly, S., Palmer, C. N. A., Plutzky, J., Reddy, J. K., Spiegelman, B. M., Staels, B., Wahli, W.
(2006). International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors. Pharmacol. Rev.
58: 726-741
[Abstract]
[Full Text]
Copyright © 2006 by the American Society for Microbiology. All rights reserved.